Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2024
6-1-2024 Navigating the Complexities of Brain Metastases Management, Afsaneh Amouzegar, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Shannon Haig, Lake Erie College of Osteopathic Medicine, Greensburg, PA., Adriana M. Kahn, Section of Medical Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT., et al.
6-1-2024 Unveiling a low-hanging fruit: Single-center study on secondary immunodeficiency in newly diagnosed chronic lymphocytic leukemia and multiple myeloma, Zeni Kharel, Rochester Regional Health, Himal Kharel, Rochester Regional Health, S. Shahzad Mustafa, Rochester Regional Health, et al.
6-1-2024 When pain management meets harm reduction: Patients with cancer navigate the opioid crisis—2016 to 2020 National Inpatient Sample analysis, Himal Kharel, Rochester Regional Health, Zeni Kharel, Rochester Regional Health, Samikchhya Keshary Bhandari, Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal., et al.
5-1-2024 Abstract PO1-07-12: Inverse modeling with surface temperature accurately detects the presence of breast cancer, Nithya Sritharan, Rochester Regional Health, Carlos Gutierrez, Isaac Perez-Raya, et al.
5-1-2024 Abstract PO3-06-03: Overall Survival and Disease Interval Among Breast Cancer Subtypes in Patients with Brain Metastasis, Asis Shrestha, Sugam Gouli, Rochester Regional Health, Sujan Niraula, et al.
5-1-2024 Abstract PO4-20-11: Excellent Response to Trastuzumab Deruxtecan in “HER-2 Low” Leptomeningeal Breast Cancer and Diagnostic and Monitoring Utility of CNSide Assay, Sarah Stanford, Zeni Kharel, Rochester Regional Health, Lauryn Hemminger, et al.
5-1-2024 Transplacental transfer of emicizumab: Experience with emicizumab in a pregnant female with severe hemophilia A and an inhibitor, Zeni Kharel, Rochester Regional Health, Rajiv K. Pruthi, Division of Hematopathology, Comprehensive Hemophilia Center and Special Coagulation Laboratory, Mayo Clinic, Rochester, Minnesota, USA., Peter Kouides, Rochester Regional Health, et al.
4-18-2024 Immune-Related Adverse Events of Immune Checkpoint Inhibitors, Charoo Iyer, Rochester Regional Health; Chengu Niu, Rochester Regional Health; Ido Goldenberg, Rochester Regional Health; and Mehul Patel, Rochester Regional Health
4-1-2024 Clinical characteristics of HFE C282Y/H63D compound heterozygotes identified in a specialty practice: key differences from HFE C282Y homozygotes, Mukul Singal, Rochester Regional Health; Amir Mahmoud, Rochester Regional Health; and Pradyumna Dinkar Phatak, Rochester Regional Health
3-21-2024 Acute Bleeding Catastrophe: A FACTOR to consider, Harkarandeep Singh, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health
3-21-2024 Narrative medicine interventions for oncology clinicians: a systematic review, Trisha K. Paul, Department of Oncology, Division of Quality of Life and Palliative Care, St. Jude Children's Research Hospital, Memphis, TN, USA., Yashaswi Reddy, Kakatiya Medical College, Warangal, Telangana, India., Anthara Gnanakumar, George Washington University School of Medicine, Washington, DC, USA., et al.
2-29-2024 Women and Bleeding Disorders, Robin M. Reid, Rochester Regional Health
2-9-2024 Breast cancer detection using enhanced IRI-numerical engine and inverse heat transfer modeling: model description and clinical validation, Carlos Gutierrez, Rochester Institute of Technology, Rochester, USA., Alyssa Owens, Rochester Institute of Technology, Rochester, USA., Lori Medeiros, Rochester Regional Health, et al.
2-1-2024 Collaborative Care: A Model for Embedding Counseling in Oncology and Palliative Care, Earon Lehning, Rochester Regional Health
2-1-2024 Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta-analysis based on revised criteria by the International Working Group for thrombotic thrombocytopenic purpura, Niraj Neupane, Rochester Regional Health, Sangharsha Thapa, Kathmandu University School of Medical Sciences Dhulikhel Nepal., Amir Mahmoud, Rochester Regional Health, et al.
2-1-2024 Should primary care physicians consult on their admitted patients? A single-center survey study, Basil George Verghese, Rochester Regional Health, Mohamed Salah Mohamed, Rochester Regional Health, Anas Hashem, Rochester Regional Health, et al.
1-1-2024 ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms, Hassan Awada, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Manasa Bhatta, Department of Medicine, The Mount Sinai Hospital, New York, NY, USA., Han Yu, Department of Biostatistics & Bioinformatic, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., et al.
1-1-2024 Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia, Niraj Neupane, Rochester Regional Health, Soon K. Low, Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Himal Kharel, Rochester Regional Health, et al.
Submissions from 2023
12-1-2023 Comparative Analysis of Palliative Care Needs Identified in Inpatient Rehabilitation and Skilled Nursing Facilities by Multidisciplinary Team Members, Erin Kelly; Elizabeth Spina, Rochester Regional Health; and John Liantonio
12-2023 Spinal Plasmacytoma Transformed into Solitary Sacral Amyloidoma: A Case Report, Niraj Neupane, Rochester Regional Health, Himal Kharel, Rochester Regional Health, Mohammad Ammad Ud Din, Hematology/Oncology, H. Lee Moffitt Cancer and Research Institute, Tampa, Florida., et al.
11-2-2023 Comparative Analysis of Hospital Outcomes for Thrombotic Thrombocytopenic Purpura between 2018 and 20120: A National Inpatient Sample Database Study, Niraj Neupane, Rochester Regional Health, Arnav Srivastava, Rochester Regional Health, Shubham Agrawal, et al.
11-2-2023 Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients; A Scoping Review, Olga Lytvynova, Jenna Jwayyed, Maha Hameed, et al.
11-2-2023 Transplacental Transfer of Emicizumab: Experience with Emicizumab in a Pregnant Female with Severe Hemophilia Α and an Inhibitor, Zeni Kharel, Rochester Regional Health, Rajiv K. Pruthi, Peter A. Kouides, Rochester Regional Health, et al.
11-1-2023 Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities, Marshall A. Lichtman, James P. Wilmot Cancer Institute, University of Rochester Medical Center. and Ronald Sham, Rochester Regional Health
11-2023 P2.17-07 Real-world Safety and Dosing of Lurbinectedin-Treated Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Preliminary Analysis, B. Halmos, Albert Einstein College of Medicine, Bronx, United States, P. Lammers, Baptist Cancer Center, Memphis, United States, Mehul Patel, Rochester Regional Health, et al.